ArticleJournal for immunotherapy of cancer2025

Targeting IL13Rα2 in melanoma with a bispecific T-cell engager: expression profiling and preclinical evaluation.

Shushu Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.